Salud financiera de hoja de balance de Nanjing Vazyme Biotech
Salud financiera controles de criterios 4/6
Nanjing Vazyme Biotech has a total shareholder equity of CN¥3.9B and total debt of CN¥500.9M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥4.9B and CN¥959.4M respectively.
Información clave
12.7%
Ratio deuda-patrimonio
CN¥500.92m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CN¥2.47b |
| Patrimonio | CN¥3.94b |
| Total pasivo | CN¥959.43m |
| Activos totales | CN¥4.90b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 688105's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥731.2M).
Pasivo a largo plazo: 688105's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥228.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 688105 has more cash than its total debt.
Reducción de la deuda: 688105's debt to equity ratio has reduced from 18% to 12.7% over the past 5 years.
Cobertura de la deuda: 688105's debt is not well covered by operating cash flow (14.3%).
Cobertura de intereses: Insufficient data to determine if 688105's interest payments on its debt are well covered by EBIT.